使用生理学基础的药理动力学建模,对人类局部氨酸的眼睛暴露预测
Aole Zheng1, Tian Han2,3,4,5, Fengjiao Bu6
1Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, 201203, China.
The AAPS journal
|May 2, 2025
概括
一个新的数学模型预测了眼睛中的氨酸分布,有助于儿童控制近视. 这种基于生理学的药理动力学 (PBPK) 模型准确地预测了眼睛的暴露和透,提供了对氨酸的洞察力.
科学领域:
- 药理动力学和药理动力学
- 眼部药物输送 眼部药物输送
- 数学建模的数学建模
背景情况:
- 氨酸用于减少儿童近视的进展.
- 了解氨酸的眼部分布和生物可用性对于优化治疗至关重要.
- 基于生理学上的药理动力学 (PBPK) 模型为预测特定器官中药物行为的强大工具.
研究的目的:
- 开发一个人类眼部PBPK模型用于阿特罗宾.
- 探索氨酸减少近视进展的机制.
- 为了验证模型跨物种的预测准确性.
主要方法:
- 使用了眼腔腔吸收和传输 (OCATTM) 模型.
- 使用子和人类研究数据开发并验证了眼部PBPK模型.
- 在各种剂量下模拟了氨酸的分布和暴露.
主要成果:
- OCAT-PBPK模型与子眼组织和人类水性幽默的实验数据有很好的一致性.
- 58%的模拟在实验数据的标准偏差范围内.
- 人类PBPK模型准确地预测了低度氨酸的眼睛暴露和分布.
结论:
- 开发的眼部PBPK模型有效地预测了跨物种的阿特罗宾的药理动力学行为.
- 阿特罗平显示出透眼睛后部部位的巨大潜力.
- 该模型为控制近视的阿特罗宾的作用机制提供了有价值的见解.
相关概念视频
Pharmacokinetic Models: Overview
493
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
493
Pharmacokinetic Models: Comparison and Selection Criterion
20
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
20
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
854
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
854
Direct-Acting Cholinergic Agonists: Pharmacokinetics
976
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
976
Open Angle Glaucoma: Treatment
356
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
356
One-Compartment Open Model for IV Bolus Administration: General Considerations
112
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
112


